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Multiple Sclerosis (MS), an autoimmune demyelinating disease affecting the central nervous 
system (CNS), causes tremendous disability in young adults and inflicts a huge economic burden 
on the society. Currently, more than 2.5 million people are affected by MS worldwide and the 
incidence is steadily increasing in most countries (Pugliatti et al., 2002). The disease progression in 
individual patients often takes different courses eventually leading to severe functional deficits 
which include inability to walk without support, cognitive decline etc. Functional deficits in MS are 
caused by focal lesions in the CNS white matter predominantly composed of immune cell infiltrates 
(Hauser and Oksenberg, 2006; Sospedra and Martin, 2005). These infiltrating immune cells recruit 
additional immune cells and also activate local resident cells to orchestrate a pathogenic cascade 
inflicting demyelination and axonal damage.  
Genetic factors clearly predispose a particular individual to the development of MS. In support of 
this, genome wide association studies identified many genes, in particular immunologically relevant 
genes, as risk factors for MS susceptibility (Sawcer et al., 2011). However, the low concordance 
rate of approximately 30% between monozygotic twins to develop MS indicates an important and 
significant role of environmental factors in disease initiation. Moreover, the striking increase in the 
incidence of MS within the last few decades cannot be entirely attributed to genetic changes. 
Although clear causative environmental factors are not known, analysis of epidemiological data 
suggests vitamin D, smoking and Epstein-Barr-Virus (EBV) infection as potential risk factors for 
triggering MS (Ascherio and Munger, 2008). The high prevalence of MS also coincides with the 
improved lifestyle and high standards of hygiene which reduce the burden of infections but can also 
limit exposure to microbes that are potentially beneficial for healthy activation of the immune 
system (Bach, 2002; Okada et al., 2010). While the importance of the immune mediated pathology 
in MS has been firmly established, how the CNS-specific autoimmune responses are initiated is 
poorly understood. Moreover, it is not clear what triggers relapses of clinical episodes in relapsing-
remitting MS patients. While the currently available animal models greatly allow us to understand 
the effector phase of the autoimmune disease, they were not useful to study the triggering phase of 






1.1. Experimental autoimmune encephalomyelitis: an animal model of 
multiple sclerosis 
  
 Experimental autoimmune encephalomyelitis (EAE) induced in rodents is the common model of 
choice to study CNS autoimmune responses. Typically, two types of models have been used: 
actively induced EAE or passive transfer EAE. The active EAE induction protocols require complete 
Freund’s adjuvant (CFA) as an adjuvant which facilitates the gradual release of antigen into the 
draining lymph nodes and at the same time amplifies the immune response by activating innate 
immune system. Pertussis toxin is also combined with EAE induction in mice (Linthicum et al., 
1982). Passive EAE induction relies on the transfer of encephalitogenic T cells clones or lines 
obtained from immunized animals and stimulated in vitro by the autoantigen (Wekerle et al., 1994). 
However, these induced models have several drawbacks. These artificial models poorly reflect the 
true pathogenic mechanisms of MS and are often too simplistic, focusing mainly on T cell 
responses.  Later, many transgenic models have been developed to interrogate the pathogenic 
mechanisms of CNS autoimmunity. These include transgenic mice expressing the susceptible 
human leucocyte antigen (HLA) genes from patients, targeted expression of the cytokines and 
chemokines in the CNS and T cell receptor and B cell receptor transgenic mice (Krishnamoorthy et 
al., 2007). 
1.1.1. Spontaneous EAE models 
 
 The development of alternative class of models which overexpress myelin-specific T- or B-cell 
receptors resulted in spontaneous neurological symptoms with varied incidence and clinical 
patterns (Krishnamoorthy et al., 2007). These models are entirely murine or “humanized” for the T 
cell receptor (TCR) and associated antigen presenting molecules. The first TCR transgenic mouse 
model was generated by Goverman and colleagues which recognized the I-Au restricted myelin 
basic protein (MBP) Ac1-11 peptide (Goverman et al., 1993; Lafaille et al., 1994). The MBP-specific 
TCR transgenic mice spontaneously developed neurological symptoms (~14 - 44%) under 
conventional housing but not in specific pathogen free (SPF) conditions (Goverman et al., 1993). 
Interestingly, the spontaneous EAE incidence reached 100% in the absence of regulatory T cells 
(Treg) and B cells in mice lacking functional RAG genes. Later, proteolipid protein (PLP) 139-151 
specific TCR transgenic mice were developed which showed severe spontaneous EAE on the 
susceptible SJL/J background and remained healthy in resistant B10.S background (Waldner et al., 
2000). Following this, a myelin oligodendrocyte glycoprotein (MOG) 35-55 specific TCR transgenic 
mouse in C57BL/6 background was generated which showed signs of isolated optic neuritis (>30%) 





important role of T cells in CNS autoimmunity, the role of other immune cells in particular B cells 
were not addressed in these models.  
 
1.2. Triggers and pathogenic events in CNS autoimmunity 
  
 Many cellular players contribute to CNS autoimmunity. The ease with which myelin-specific 
CD4+ T lymphocytes are isolated from rodents and humans as well as their ability to transfer EAE 
to naïve recipients suggests that CD4+ T lymphocytes are the main culprits inducing CNS damage 
(Wekerle, 1993). Animal models that were used to mimic MS are predominately based on CD4+ T 
cells. Numerous efforts were undertaken to define the effector phenotype of CD4+ T cells, which 
alone can induce inflammation in the CNS. However, it became clear that all CD4+ T cell-subsets, 
be it IFN-γ-producing TH1 cells or IL-17-producing TH17 cells, are capable of mediating EAE in 
different settings (Domingues et al., 2010; Jäger et al., 2009). Nevertheless, MS lesions contain 
higher frequencies of CD8+ than CD4+ T lymphocytes (Babbe et al., 2000). Reports showed that 
myelin-specific CD8+ T cells can also induce EAE (Ford and Evavold, 2005; Sun et al., 2001) and 
cytotoxic T cells are able to contribute to CNS pathology (Na et al., 2008; Saxena et al., 2008). The 
type II histological patterns of MS lesions as well as the presence of oligoclonal bands in the 
cerebrospinal fluid (CSF) of MS patients suggests, in addition to T cells, a contribution of B 
lymphocytes to the pathogenesis of the disease (Lucchinetti et al., 2000; Owens et al., 2006). 
Moreover, rituximab, a B cell-depleting monoclonal antibody, was effective in a subset of MS 
patients (Owens et al., 2006).  
 The central question, which remains still unanswered, is how the CNS autoimmune responses 
are initiated. For long time, pathogenic infections were suspected to be the triggers of MS. Among 
viral infections, human herpes virus 6 (HHV-6) and Epstein-Barr virus (EBV) were widely studied as 
initiators of the disease (Ascherio and Munch, 2000; Challoner et al., 1995). Similarly, bacterial 
pathogens such as Chlamydia pneumonia, a Gram-negative intracellular bacterium, have been 
associated with MS, although the data is controversial (Sriram et al., 1999). However, none of the 
proposed infectious trigger has been definitively proven.  
 The overall rise in incidence of many autoimmune diseases including MS suggests a common 
causative environmental factor. The hygiene hypothesis states that the lack of childhood exposure 
to infections increases the susceptibility to autoimmune and allergic disorders (Bach, 2002; Okada 
et al., 2010). Emerging evidence from various autoimmune disease models suggests a role for 
resident gut microbiota in the pathogenesis of autoimmune diseases (Chervonsky, 2010). So far, 





role of gut microbiota stems from the fact that dietary factors (potent modulators of gut microbiota 
composition and function (David et al., 2014; Maslowski and Mackay, 2011)) like milk, animal fat 
and meat are positive influencers of MS incidence (Lauer, 1994, 1997). Interestingly, recent studies 
have linked MS incidence to lifestyle factors that have been shown to interfere with the 
establishment of healthy bacterial populations in the gastrointestinal tract, such as early-life 
antibiotics (Norgaard et al., 2011), formula feeding (Conradi et al., 2013), and caesarian sections 
(Maghzi et al., 2012). Although the role of gut microbiota was not directly investigated in these 
studies, these lifestyle factors may hurt the transmission of microbiota, likely leading to aberrations 
of the gut microbiota. Another interesting data showed that the MS disease course was milder in 
inflammatory bowel disease (IBD) patients, who are known to have an altered gut microbial profile 
(Zéphir et al., 2013).  
 The potential involvement of gut microbiota in CNS autoimmunity came from work in the animal 
models of MS. Early studies using MBP-specific TCR transgenic mice showed that SPF mice (with 
a normal gut microbiota) were less prone to develop EAE than mice housed in a conventional, 
“dirty” facility (Goverman et al., 1993). However, a specific trigger has not been identified to date. 
Later studies using antibiotic treatments to reduce the gut bacterial load also showed that EAE 
severity is reduced in mice and rats (Ochoa-Repáraz et al., 2009; Wekerle et al., 2013; Yokote et 
al., 2008). Two recent studies suggested that the hallmark of westernized life style, “high salt” diet 
consumption led to severe EAE in mice (Kleinewietfeld et al., 2013; Wu et al., 2013), indirectly 
supporting a role for gut microbiota. Attempts to relate the influence of gut microbiota to the 
susceptibility of EAE by active immunization have yielded contradictory results. One group noted no 
difference between germ free (GF) and SPF mice (Lampropoulou et al., 2008) while a very recent 
report (Lee et al., 2011) found reduced EAE susceptibility in GF C57BL/6 mice. Obviously the use 
of CFA immunization will supersede a potential role of commensal microbiota. Spontaneous 
models sparing any artificial immunization will be superior in addressing these important questions 








 Although we have learned a lot about the immunopathogenesis of MS using induced EAE 
models, there remains a knowledge gap regarding the disease triggering mechanisms. 
The central question of my work is:  
What are the triggers of CNS autoimmunity? 
To answer this question, the following developments were made 
- Generation of spontaneous EAE models (described in publications 1 & 2) 
- Contribution of B cells to spontaneous EAE pathogenesis (described in publications 1 & 2) 
- Cumulative autoimmunity (described in publication 3) 






3. Results and discussion 
3.1. Spontaneous EAE models of MS 
To investigate the triggering mechanisms of CNS autoimmunity, it is essential to use the animal 
model which develops spontaneous neuroinflammation at high frequency. We developed two new 
mouse models based on the transgenic expression of myelin antigen-specific T and B cell 
receptors. The first mouse model utilizes the TCR transgenic mice (2D2; TCRMOG) whose T cells 
recognize the MOG 35-55 peptide in the context of I-Ab and express the rearranged TCRα and β 
chain from the pathogenic T cell clone obtained from immunized animals (Bettelli et al., 2003). A 
significant proportion (>30%) of these mice develop spontaneous optic neuritis without evidence of 
clinical or histological signs of EAE and around 4% of the mice developed spontaneous EAE at 
older age. B cell receptor (BCR) knock-in mice (IgHMOG) were produced by gene targeting of the 
rearranged heavy chain VDJ sequence from the MOG specific hybridoma 8.18-C5 to its natural 
locus (Litzenburger et al., 1998). This heavy chain recognizes the conformational epitope present in 
the extracellular portion of MOG. B cells in IgHMOG mice develop normally and secrete high titers of 
pathogenic antibodies. However, these mice never show autoimmunity, but enhanced kinetics of 
EAE after immunization was observed.  
In an attempt to shed light on the involvement of myelin autoantigen specific T and B cells and 
their products in CNS autoimmunity, we crossed 2D2 mice with IgHMOG mice (Figure 1). 
Unexpectedly, we observed that a high proportion of these double-transgenic mice spontaneously 
developed severe EAE at young age. CNS inflammation in the double-transgenic mice was focused 
to spinal cord and optic nerve, leaving unaffected the brain and cerebellum, leading us to dub these 
animals as Opticospinal Encephalomyelitis (OSE) mice. The lesions presented severe 
demyelination and infiltration by inflammatory cells, predominantly macrophages and CD4+ T cells, 
but also eosinophilic leukocytes (Krishnamoorthy et al., 2006) (Publication 1). 
Spontaneous EAE in OSE mice takes a chronic-progressive course. This is not surprising, since 
it is known that C57BL/6 mice respond to active induction of EAE with chronic, not relapsing-
remitting disease. In an attempt to develop an experimental model which would present 
spontaneous relapsing remitting disease, we used the SJL/J mouse strain, which is known to 
develop relapsing-remitting EAE following active immunization or passive transfer. We raised a 
highly encephalitogenic and MOG-specific SJL/J T cell clone which uses a TCR composed of 





pronuclear injection. These animals developed spontaneous relapsing-remitting EAE, hence 
dubbed as RR mice (Figure 1).  
 
 The large confluent demyelinating plaque-like lesions were located in the cerebellum and the 
spinal cord. Importantly, RR mouse lesions feature local immunoglobulin deposits along with 
activated complement complexes. This is remarkable, considering that the only change of these 
mice is the expression of transgenic TCR genes, resulting in an overrepresentation of MOG-
specific T cells in their CD4+ T cell repertoire. Consequently, the autoantibody-producing B cells 
must be recruited from the natural B cell repertoire. Evidence indicates that the selection, activation 
and differentiation of autoantibody-producing B cells takes place in germinal centers of the cervical 
lymph nodes, which are directly connected to the CNS via lymphatic vessels. The process of B cell 





MOG-specific antibodies were not present in the MOG-deficient RR mice (Pöllinger et al., 2009) 
(Publication 2). 
3.2. B cells in spontaneous EAE models 
 While the role of T cells has been extensively explored in EAE models, the role of B cells in the 
immunopathogenesis of EAE was not clear. B cells can serve as APCs, produce 
cytokines/chemokines or secrete antibodies. Especially our two spontaneous EAE mouse models, 
OSE mouse (Bettelli et al., 2006; Krishnamoorthy et al., 2006) and RR mouse (Pöllinger et al., 
2009), highlight the importance of B cell functions in disease pathogenesis.  
 To explore the role of B cells in our mouse models, we cultured spleen cells from OSE mice with 
serially diluted concentrations of recombinant MOG protein. We found that MOG-specific B cells in 
OSE mice enhanced the activation of MOG-reactive T cells even at very low concentrations of 
MOG. This was due to their specific membrane receptors through which they can specifically 
capture and concentrate MOG and hence present it more efficiently to T cells. In this co-culture, we 
observed that both T and B cells proliferated vigorously and expressed activation markers such as 
CD25 and CD86, respectively. In sharp contrast, single transgenic T cells required more than 100 
fold higher MOG protein amounts to exhibit a similar proliferation while B cells responded only 
weakly. The efficient presentation of MOG required conformational MOG since MOG-specific B 
cells were not as efficient to present the MOG 35-55 compared to MOG protein (Figure 2).  
 Since B cells can also produce autoantibodies, we measured MOG-specific antibodies in the 
serum of OSE mice. We found high titers of isotype switched MOG-specific IgG1 or IgG2a 
antibodies in the serum of both healthy and EAE affected OSE mice (Bettelli et al., 2006; 
Krishnamoorthy et al., 2006). In contrast, isotype switched antibodies were present in much lower 
concentrations in single transgenic IgHMOG mice,  suggesting a T cell driven activation and 
subsequent isotype switching of MOG-specific B cells. However, we did not find a deposition of 
antibodies in the CNS lesions of EAE-affected OSE mice. Moreover, the onset of clinical symptoms 
did not affect the level or nature of MOG-specific antibodies. Finally, MOG-deficient OSE mice also 
harbored higher amounts of MOG-specific antibodies suggesting their generation occurred 
independently of MOG antigen (Figure 2). Collectively, the OSE mouse model supports the concept 






 We performed similar antigen presentation assays in RR mice but failed to find appreciably 
higher antigen presentation capacity of B cells from RR mice compared to controls. Surprisingly, 
however, we found that RR mice spontaneously produced MOG-specific autoantibodies 
presumably due to the recruitment of MOG-reactive B cells from the endogenous B cell repertoire 
by activated T cells (Pöllinger et al., 2009).  We also found extensive deposits of MOG-binding 
antibodies in the CNS lesions of RR mice, suggesting the importance of MOG-specific antibodies in 
the pathogenesis. The B cell response in RR mice was a specific response to MOG rather than a 
broad autoreactivity since we did not find antibodies against other autoantigens. The autoantibodies 
appeared in serum from 5 weeks of age, and persisted up to 6 months of age and started declining 
thereafter (Pöllinger et al., 2009). There is evidence that conformational epitope but not linear 
epitope binding autoantibodies are involved in EAE pathogenesis (von Büdingen et al., 2002). We 
tested the serum of RR mice on cell bound MOG and found that majority of these antibodies were 
indeed recognizing conformationally intact MOG expressed on the cell surface. We next performed 





dose PLP peptide immunization. We noted a significant aggravation of EAE in mice that received 
RR mouse serum compared to non-transgenic littermate serum recipients. To examine the 
importance of B cells, we performed B cell depletion experiments using anti-CD20 antibodies. B cell 
depletion had contrasting impact on spontaneous EAE depending upon the time point of depletion.  
While neonatal B cell depletion suppressed spontaneous EAE (Figure 3), adult B cell depletion 
increased EAE incidence. It can be concluded that while B cells are necessary for the efficient 







Overall, our and other studies indicate a diverse role for B cells in MS. Unraveling the 
pathophysiological effects mediated by B cells and/or antibodies in patients is essential if we are to 
exploit these observations to develop new therapeutic strategies for MS, particularly in view of the 
clinical and mechanistic heterogeneity of the disease. 
3.3. Cumulative autoimmunity 
 Molecular mimicry, a cross-reaction of autoaggressive T cells to pathogen-derived molecules, 
has been suggested as a mechanism by which tolerance against autoantigens can be broken 
(Fujinami et al., 1983; Oldstone, 1987). While studying the role of the autoantigen in spontaneous 
MOG-directed EAE, we bred the MOG-specific TCR transgenic 2D2 mice on a MOG-deficient 
background. Unexpectedly, we noted spontaneous EAE in MOG-deficient 2D2 mice with incidence 
and kinetics indistinguishable from their wild type counterparts (Krishnamoorthy et al., 2009). EAE 
in MOG-deficient 2D2 mice could have been due to several possibilities: aberrant expression of 
truncated protein, recruitment of endogenous TCR specific for other myelin antigen or 2D2 TCR 
cross reacting with another myelin autoantigen. Our western blot analysis ruled out any residual 
MOG protein in MOG knock out mice. The flow cytometry analysis also did not find endogenous 
TCR expression that is reactive to other myelin antigens.  
 After excluding incomplete ablation of MOG or an autoimmune attack by T cells from the 
residual endogenous repertoire as possible explanations, we probed the possibility that other CNS 
protein(s) could serve as an alternative autoantigen in the paradoxical EAE response. Using a 
purification strategy to separate the CNS proteins from MOG-deficient mice and subsequent in vitro 
recall assay with 2D2 T cells, we identified several fractions that efficiently activated 2D2 T cells. 
We performed mass spectrometry analysis of the 2D2 T cell activating fractions and identified the 
medium sized neurofilament (NF-M) as an alternative target for 2D2 T cells. An in silico search 
identified a seven amino acid peptide of NF-M that is nearly identical to the core region of the 
antigenic peptide MOG38–50. The dominant epitopes of MOG and NF-M shared several important 
TCR contact positions that contain the amino acids Arg41, Phe44, Arg46 and Val47, which are 
known to be the crucial contact amino acids for the 2D2 TCR and other MOG-specific T cell lines 
(Ben-Nun et al., 2006; Petersen et al., 2004). We confirmed the reactivity of 2D2 T cells to NF-M by 
using synthetic peptide and the recombinant NF-M protein (Figure 4). Interestingly, the cross-
reactivity between NF-M and MOG-specific T cells is not a phenomenon unique to the transgenic 







 To determine the in vivo recognition of NF-M by 2D2 T cells, we transferred activated 2D2 T 
cells into RAG-/- and RAG-/- x MOG-/- mice. Whereas both recipient groups developed EAE, in 
MOG-deficient Rag2-/- mice the disease was delayed. Similarly, NF-M–activated 2D2-expressing T 
cells also triggered EAE in WT hosts with the same incidence and kinetics as that of MOG-
activated 2D2 T cells. Thus, we found the first example of immunological self-mimicry, i.e., the 
response of one T cell population against two target autoantigens in the same tissue, MOG and 
NF-M (Krishnamoorthy et al., 2009). We postulate that the combined response of a T cell clone 
against two independent autoantigens presented within the same target tissue initiates a 
particularly vigorous autoimmune attack. Such a cumulative autoimmune response may explain 
why the MOG epitope 35-55 elicits EAE in C57BL/6 mice, which otherwise are resistant against 






3.4. Gut Microbiota as a trigger of spontaneous CNS autoimmunity  
 
 While the triggering mechanisms of autoimmune diseases still remain an unanswered question, 
the overall rise in the incidence of many autoimmune diseases suggests a common causative 
environmental factor. The hygiene hypothesis states that the lack of childhood exposure to 
infections increases the susceptibility to autoimmune and allergic disorders (Bach, 2002; Okada et 
al., 2010). Emerging evidence from various autoimmune disease models suggests a role for the 
resident gut microbiota in the pathogenesis of autoimmune diseases (Chervonsky, 2010). So far, 
there is no direct evidence implicating gut microbiota in triggering MS. The indirect evidence for the 
role of gut microbiota stems from the fact that dietary factors (potent modulators of gut microbiota 
composition and function (David et al., 2014; Maslowski and Mackay, 2011)) like milk, animal fat 
and meat are positive influencers of MS incidence (Lauer, 1994, 1997).   
Having distributed our RR mice to different pathogen-free facilities, we noted incidences of 
spontaneous EAE ranging between 35–90%, a variation, which could simply not be explained by 
varying “hygienic conditions”. To test the possible contribution of non-pathogenic commensal 
microbiota to EAE triggering, we re-derived RR mice into GF, devoid of commensal flora, 
conditions. Strikingly, we noted a complete protection from spontaneous RR EAE in GF mice 
compared to our normal SPF housed mice (Berer et al., 2011). Re-colonization of GF RR mice with 
regular flora from SPF mice promptly restored spontaneous EAE suggesting a vital role for 
commensal flora in disease induction (Figure 5). 
 Protection from EAE went along with a drastic reduction in the frequency of TH17 cells in the 
lamina propria and Peyer’s patches of GF mice suggesting a possible activation of MOG-specific T 
cells in the gut associated lymphoid tissue (GALT) (Berer et al., 2011). Indeed, CFSE labeled T 
cells transferred into SPF mice proliferated predominantly in the GALT, a response abolished after 
short-term antibiotic treatment. There is increasing evidence that the gut microbiota not only 
activates the pro-inflammatory effector T cells but also induces autoimmune disease suppressing 
regulatory T cells depending upon the presence of particular species. For example, segmented 
filamentous bacteria (SFB) predominantly induce pro-inflammatory TH1 and TH17 cells (Gaboriau-
Routhiau et al., 2009; Ivanov et al., 2009) whereas clostridium species from both humans and mice 
induce regulatory T cells (Atarashi, 2011; Atarashi et al., 2013).  However, mono-association of GF 






Activation of MOG-specific T cells is necessary but not sufficient for full clinical EAE. MOG-
specific B cells recruited from the native immune repertoire by T cells play an additional crucial role 
in the EAE development by producing demyelinating antibodies. In GF mice, in the absence of T 
cell activation, B cell recruitment was impaired, as reflected by reduced production of MOG-binding 
serum antibodies. Spontaneous production of anti-MOG antibodies also required the expression of 
MOG antigen in the CNS. RR mice deficient in MOG (RR x MOG-/-) failed to develop anti-MOG 
autoantibody titers despite their normal microbial status. We localized the recruitment of MOG-
specific B cells to CNS draining lymph nodes by transferring GFP-labeled transgenic MOG-specific 
B cells. We found that MOG-specific B cells specifically accumulated in the germinal centers of 
cervical lymph nodes of SPF mice but not in any other peripheral lymph nodes. This migration was 
not seen in RR x MOG-/- recipients (Berer et al., 2011). Together, our work identifies a sequence of 







 It is widely believed that autoimmune diseases arise due to the combination of several factors 
such as genetic susceptibility and environmental triggers. Epidemiological studies strongly suggest 
that allergic and autoimmune diseases are clearly on the rise in developed countries. But infectious 
agents show a complex relationship with autoimmunity. While lack of infection favours 
autoimmunity, infection can also precipitate autoimmunity (Bach, 2002);(Christensen, 2005). In the 
case of MS, there were numerous studies that show that immune cells, in particular T cells, play a 
major role in disease pathogenesis. However, there is a huge gap in understanding the triggers of 
autoimmune reactivity.  
To understand “What are the triggers of CNS autoimmunity?” new spontaneous EAE mouse 
models were developed. These models differed in their clinical characteristics, pathology and 
pathogenesis. While in OSE mice B cells primarily served as antigen presenting cells, 
autoantibodies played a crucial role in the demyelination in RR mice. Also, these models led us to 
identify a novel phenomenon of autoimmune cross reactivity, i.e., self-molecular mimicry which we 
termed as “Cumulative autoimmunity”. 
One of the most important uses of these models was to investigate the actual triggering mechanism 
of the CNS autoimmunity. Our studies identified that the commensal gut microbiota through 
modulating the immune functions triggered CNS autoimmune reactivity. Mechanistically, how the 
gut microbiota modulates autoimmune responses against the remote CNS is yet to be understood. 
The gut microbiota effects can be transmitted to remote organs through a) trafficking of adaptive 
and innate immune cells stimulated in the intestine b) transport of bacterial metabolites c) 
translocation of live bacteria due to impaired epithelial integrity. These are the potential lines of 
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